Codman Neurovascular Launches Orbit Galaxy Detachable Coil System

Codman & Shurtleff Inc., a global neuroscience and neurovascular company, today announced the launch of the ORBIT GALAXY Detachable Coil System (ORBIT GALAXY), the first complete family of complex, random loop coils for the endovascular treatment of cerebral aneurysms.

ORBIT GALAXY includes the complete range of stretch resistant Frame, Fill and XTRASOFT Finishing coils required to treat aneurysms.  The new coils feature a unique, complex random loop design. This shape makes the coils highly conformable and enables them to seek and fill open spaces in cerebral aneurysms to achieve high packing densities, which have been correlated with low patient retreatment rates.

ORBIT GALAXY leverages design elements from CODMAN’s TRUFILL DCS ORBIT coils, but adds new features including stretch resistance, the soft, complex XTRASOFT Finishing coil, and the stable, conformable Frame coil.

“Codman developed this family of endovascular coils to offer physicians a total procedural solution that can be used to treat the majority of cerebral aneurysms from start to finish,” says P. Laxmin Laxminarain, Worldwide President of Codman.  “We have retained the best elements of the TRUFILL DCS ORBIT System and added new features and components that make ORBIT GALAXY a next generation system that fills important clinical and patient needs.”

Codman’s proprietary manufacturing process gives each coil its own unique and random, complex shape.  The use of complex, random loop coils have been shown to result in significantly higher packing than helical coils and complex coils with pre-determined shapes.

“The ORBIT GALAXY family of coils leverages proven and reliable coil technology with important new developments.  The conformability and softness of these stretch resistant coils enables physicians to confidently fill an aneurysm very densely from the periphery to the core,” says Elad I. Levy, MD, FACS, FAHA, Professor of Neurosurgery, University at Buffalo Neurosurgery, State University of New York.*  “Having a complete set of coils in one system helps streamline the procedure.”

Endovascular coils are inserted directly into an aneurysm through a microcatheter, a small, thin, hollow tube, to block blood flow and prevent rupture, which could lead to a hemorrhagic stroke, a life-threatening condition that affects about 13% of the 800,000 U.S. stroke cases each year.   According to the American Stroke Association, cerebral aneurysms affect 3 to 5 million people in the United States.

Over the last several months, Codman, through its Codman Neurovascular business unit, introduced the NEUROSCOUT Steerable Guidewire and the XTRASOFT ORBIT GALAXY Coil globally, as well as the ENTERPRISE Vascular Reconstruction Device and Delivery System in Japan for the treatment of wide-necked intracranial aneurysms.

In late 2010, Johnson & Johnson acquired Micrus Endovascular, a global developer and
manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke, which now operates
under Codman Neurovascular.